Aevis Victoria Sa · SIX:AEVS
Aevis Victoria Sa — AEVIS Holding — Investor Presentation (May 2015)
16 slides from Aevis Victoria Sa's investor presentation, May 2015
Slide 1: AEVIS Company Presentation
AEVIS Company Presentation May 2015
Slide 2: Disclaimer
Disclaimer This communication contains statements that constitute “forward‐looking statements”. In this communication, such forward‐looking statements include, without limitation, statements relating to our financial condition, results of operations and business and certain of our strategic plans an
Slide 3: AEVIS – value creation through acquisitions
AEVIS – value creation through acquisitions • Clinique de • Bethanien • Ars Medica • Valère • Montbrillant Montchoisi • OPA AEVIS • Sant’Anna • Providence • CMEV • New name • OPA VJC • Clinique de • Clinique • HDG • Lindberg AEVIS • Schmerzklinik Genolier Générale • Vente Agefi • Pyramide • SHP • Vi
Slide 4: Highlights and outlook
Highlights and outlook • Growth strategy of Genolier Swiss Medical Network SA (“GSMN”) successfully continued with the integration of the 15th clinic Strategic • Integration and growth strategy of Swiss Healthcare Properties AG (“SHP”) milestones progressing with the integration of the buildings of
Slide 5: AEVIS key financials
AEVIS key financials in thousand CHF 2011 2012 2013 2014 2015F Key figures P&L Total revenue 200'818 344'406 454'669 542'372 600'000 growth 4.4% 71.5% 32.0% 19.3% 10.6% EBITDA 24'026 39'968 60'755 65'403 EBITDA margin 11.9% 11.6% 13.4% 12.1% EBIT 8'253 16'741 26'927 28'091 EBIT margin 4.1% 4.9% 5.9%
Slide 6: Annual Results 2014 – balance sheet
AEVIS Annual Results 2014 – balance sheet In CHF '000 31.12.2014 31.12.2013 Asset base in excess of CHF 1.28 billion thanks to the Cash and cash equivalents 48'574 29'065 acquisition of VJC and Villa im Other current assets 178'700 158'114 Total current assets 227'274 187'179 Park real estate Fixed
Slide 7: Annual Results 2014 – income statement
AEVIS Annual Results 2014 – income statement In CHF '000 2014 2013 Strong revenue growth (+19.3%) through targeted acquisitions Revenue 542'372 454'669 growth 19.3% n.a. Slight decrease in EBITDA margin at 12.1%, due to the integration of Operating expenses (419'484) (341'697) EBITDA 65'403 60'755 n
Slide 8: High visibility on capital markets
High visibility on capital markets AEVIS is listed on the Domestic Standard of SIX Swiss Exchange (Ticker: AEVS) • Stock price 30.04.2015: CHF 45.75 • 60d VWAP: CHF 44.19 • Current market cap: CHF 647.8 million To diversify its financing sources, AEVIS has successfully issued three straight bonds: •
Slide 9: Leading healthcare and hotel platform strategy
Leading healthcare and hotel platform strategy 2nd largest group • Nescens ‐ live better and longer GSMN of private clinics • AEVIS’ branding strategy in Switzerland to lever selected points of Nescens excellence both within GSMN Leading luxury and VJC, and AEVIS VJC hotel collection establish b
Slide 10: AEVIS corporate governance
AEVIS corporate governance AEVIS • Board: C. Wenger, R. Loretan, A. Hubert, M. Reybier, A. Kohler, C. George financial and legal expertise • Management: A. Hubert, G. Frachon, P‐O. Haenni, M. Blaser, S. Van der Schueren • Board: R. Loretan, P. Glasson, M. Reybier, A. Hubert, A. Kohler, C. Le Dorze,
Slide 11: Genolier Swiss Medical Network SA (GSMN)
Genolier Swiss Medical Network SA (GSMN) • GSMN is the 2nd largest network of private clinics in Switzerland, present in all 3 linguistic regions Strong player in the private healthcare sector in Switzerland Reliable private alternative to the public healthcare system Leader for medical touris
Slide 12: Victoria-Jungfrau Collection AG (VJC)
Victoria‐Jungfrau Collection AG (VJC) • VJC is the leading luxury hotel group comprising four 5‐stars hotels in Swiss prime locations Zurich, Bern, Lucerne and Interlaken • AEVIS acquired 71.2% of VJC in April 2014 • The acquisition was a diversification move to consolidate AEVIS’ strategic focus on
Slide 13: Nescens
Nescens • Nescens offers innovative products and services for a better living / better aging connecting healthcare, wellness and lifestyle under a Swiss high quality brand • Nescens is applied within GSMN’s clinics as well as within VJC’s and the other affiliated hotels • Integrated approach combini
Slide 14: Swiss Healthcare Properties AG (SHP)
Swiss Healthcare Properties AG (SHP) SHP portfolio key figures • SHP is a real estate company focusing on • Healthcare properties 28 (12 sites) investments in healthcare related properties all • Rental area 120’480m2 over Switzerland • Global plot area 189’897m2 • Today, SHP owns 28 healthcare prope
Slide 15: AEVIS – Outlook 2015
AEVIS – Outlook 2015 Revenue forecast 2015 of approximately CHF 600 million (pro forma, all entities consolidated over a 12‐month period, including VJC) AEVIS will focus on continuing the growth strategy of GSMN and evaluate further opportunities in the healthcare related real estate market AEVIS wi
Slide 16: Alr\'S HOLDING
Alr\'S HOLDING